204 related articles for article (PubMed ID: 6091517)
1. [Vipomas].
Dupont C
Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
[TBL] [Abstract][Full Text] [Related]
2. [Verner-Morrison syndrome].
Fahrenkrug J; Pedersen JH; Schaffalitzky de Muckadell OB; Stadil F
Ugeskr Laeger; 1981 Oct; 143(44):2881-4. PubMed ID: 6275594
[No Abstract] [Full Text] [Related]
3. VIPoma syndrome.
Krejs GJ
Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
[TBL] [Abstract][Full Text] [Related]
4. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
Bloom SR; Polak JM
Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide-secreting tumours (vipomas) in childhood.
Long RG
J Pediatr Gastroenterol Nutr; 1983; 2(1):122-6. PubMed ID: 6310076
[No Abstract] [Full Text] [Related]
7. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
8. Preoperative localization of a vasoactive intestinal peptide-secreting tumor by transhepatic portal venous sampling.
Parkman HP; Malet PF; Ogorek CP; Burke DR; Deveney CW
Am J Gastroenterol; 1988 May; 83(5):559-63. PubMed ID: 2834945
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
[TBL] [Abstract][Full Text] [Related]
10. [Mixed endocrine tumor with atypical Verner-Morrison syndrome: dissociated responses to somatostatin infusion and surgery].
Rigaud D; Cerf M; Ou-Yan C; Arrago JP; Accary JP; Chayvialle JA; René E; Bonfils S
Gastroenterol Clin Biol; 1982; 6(6-7):563-9. PubMed ID: 6126418
[No Abstract] [Full Text] [Related]
11. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy.
Park SK; O'Dorisio MS; O'Dorisio TM
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):673-96. PubMed ID: 9113317
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of pancreatic and gastrointestinal hormone-secreting tumors].
Yamaguchi K; Abe K
Nihon Rinsho; 1983 Jun; 41(6):1231-7. PubMed ID: 6312125
[No Abstract] [Full Text] [Related]
13. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
[TBL] [Abstract][Full Text] [Related]
14. Increased tear secretion in pancreatic cholera: a newly recognized symptom in an experiment of nature.
Gilbard JP; Dartt DA; Rood RP; Rossi SR; Gray KL; Donowitz M
Am J Med; 1988 Oct; 85(4):552-4. PubMed ID: 2845780
[No Abstract] [Full Text] [Related]
15. [Vipoma of the pancreas. Apropos of a case and review of the literature].
Riestra S; Suárez A; Rodrigo L; Díaz G; Fresno M; Rodríguez M; Crespo M; Rabal A
Rev Esp Enferm Dig; 1990 May; 77(5):377-83. PubMed ID: 2167711
[TBL] [Abstract][Full Text] [Related]
16. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
17. Exacerbation of diarrhea after iodinated contrast agents in a patient with VIPoma.
Weinstein GS; O'Dorisio TM; Joehl RJ; Pokorney B; Koch KL
Dig Dis Sci; 1985 Jun; 30(6):588-92. PubMed ID: 2986921
[No Abstract] [Full Text] [Related]
18. VIPoma syndrome.
Mekhjian HS; O'Dorisio TM
Semin Oncol; 1987 Sep; 14(3):282-91. PubMed ID: 2820063
[No Abstract] [Full Text] [Related]
19. Chronic diarrhea due to VIPoma in two children.
Socha J; Dobrzańska A; Rowecka K; Cichy W; Bierła J; Stodulski J; Woźniewicz B
J Pediatr Gastroenterol Nutr; 1984; 3(1):143-8. PubMed ID: 6319655
[TBL] [Abstract][Full Text] [Related]
20. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
